Calprotectin: Test, High, Low, Causes and Clinical Meaning


◉ When the Calprotectin Test is Used

Doctors may order a calprotectin test when:

◉ How the Calprotectin Test Works

Calprotectin is a protein released by neutrophils, a type of white blood cell. When there is inflammation in the intestines, neutrophils migrate to the site and release calprotectin.

Higher calprotectin levels in stool correspond to more neutrophil activity and inflammation. The test detects and quantifies the amount of calprotectin in a stool sample.

◉ Collecting a Stool Sample

Patients collect a stool sample at home following these steps:

◉ Causes of elevated fecal calprotectin levels

◉ Understanding the Calprotectin Test Results

Results are reported as micrograms of calprotectin per gram of stool (μg/g).

Normal fecal calprotectin level

A value less than 50 μg/g is normal and does not suggest any significant intestinal inflammation. Symptoms may be due to any cause.

Limit rate

A value between 50-120 μg/g may warrant additional tests, such as endoscopy, to look for early IBD. It is recommended to repeat the calprotectin test.

High level of calprotectin

A level greater than 120 μg/g of fecal calprotectin indicates active inflammation due to IBD, infection or colorectal cancer. Follow-up colonoscopy recommended.

For IBD monitoring, calprotectin levels generally correlate with disease severity:

Decreasing calprotectin on repeat tests indicates successful IBD treatment and mucosal healing.

◉ Advantages of the Calprotectin Test

Key benefits of the fecal calprotectin test:

◉ Limitations of the Calprotectin Test

◉ Conclusion

The calprotectin stool test is a simple, noninvasive way to detect intestinal inflammation. It has an important role in determining which patients warrant further endoscopic testing. For known IBD patients, regular calprotectin monitoring provides useful insight on disease activity and response to treatment.

When interpreted in clinical context, the fecal calprotectin test provides valuable information to optimize IBD patient care.


Sources

  1. Waugh, N. (2013, November 1). Protocol. Faecal Calprotectin Testing for Differentiating Amongst Inflammatory and Non-inflammatory Bowel Diseases: Systematic Review and Economic Evaluation - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK261306/
  2. HealthMatters.io LLC. (n.d.). Calprotectin | healthmatters.io. https://healthmatters.io/understand-blood-test-results/calprotectin
  3. Mari, A., Baker, F. A., Mahamid, M., Yacoob, A., Sbeit, W., & Khoury, T. (2019). Clinical utility of fecal calprotectin: potential applications beyond inflammatory bowel disease for the primary care physician. Annals of Gastroenterology. https://doi.org/10.20524/aog.2019.0394
  4. Shaoul, R., Sladek, M., Turner, D., Paeregaard, A., Veres, G., Wauters, G. V., Escher, J. C., Dias, J. A., Lionetti, P., Staino, A., Kolho, K. L., De Ridder, L., Nuti, F., Cucchiara, S., Sheva, O., & Levine, A. (2012). Limitations of Fecal Calprotectin At Diagnosis in Untreated Pediatric Crohnʼs Disease. Inflammatory Bowel Diseases, 18(8), 1493–1497. https://doi.org/10.1002/ibd.21875
  5. Testing.com. (2021, November 9). Calprotectin fecal test - testing.com. https://www.testing.com/tests/calprotectin/
  6. Whelan, C. (2023, July 31). What to know about the Calprotectin stool Test. Healthline. https://www.healthline.com/health/crohns-disease/calprotectin-stool-test